Page last updated: 2024-11-06

triethylenemelamine and Uremia

triethylenemelamine has been researched along with Uremia in 3 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MARTIN, H1
PICCINI, A1
TARGETTI, M1
KRAVITZ, SC1
DIAMOND, HD1
CRAVER, LF1

Other Studies

3 other studies available for triethylenemelamine and Uremia

ArticleYear
[Fatal uremia after triethylenemelamine treatment in chronic lymphatic leukemia].
    Klinische Wochenschrift, 1953, Mar-15, Volume: 31, Issue:11-12

    Topics: Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Triethylenemelamine; Uremia

1953
[MALIGNANT HISTOPLASMOCYTOSIS (A STATISTICO-CLINICAL STUDY)].
    Il Policlinico. Sezione medica, 1963, Volume: 70

    Topics: Adrenal Cortex Hormones; Albuminuria; Alkaline Phosphatase; Androgens; Asthenia; Blood Protein Elect

1963
Uremia complicating leukemia chemotherapy; report of a case treated with triethylene melamine.
    Journal of the American Medical Association, 1951, Aug-25, Volume: 146, Issue:17

    Topics: Humans; Leukemia; Triethylenemelamine; Uremia; Urologic Diseases

1951